Skip to main content

Table 2 Unadjusted primary outcomes by intervention periods

From: Introduction of a penicillin allergy de-labelling program with direct oral challenge and its effects on utilization of beta-lactam antimicrobials: a multicenter retrospective parallel cohort study

 

Intervention (N = 174)

Non-intervention (N = 194)

Total (N = 368)

P-Value

OR (95% CI)

Patients delabeled 30 days from admission

24 (13.8%)

3 (1.5%)

27 (7.3%)

< 0.001

10.19 (3.01–34.47)

Beta-lactam use 6 months from admissiona

28 (60.9%)

15 (37.5%)

43 (50.0%)

0.097

2.59 (1.08–6.20)

  1. Values are reported as counts (percentages) unless otherwise specified
  2. aAmong those patients who received any antibiotic